Loading...

The Scientist

» hemophilia

Most Recent

Pharmaceutical giant Sanofi to take over hemophilia drugmaker Biovertiv, while Celgene will buy cancer drugmaker Juno Therapeutics.

0 Comments

Sangamo Therapeutics will use zinc finger nucleases to introduce the gene for a missing clotting factor into the livers of men with hemophilia B.

2 Comments

image: Targeting DNA

Targeting DNA

By Jef Akst | June 1, 2012

After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.

13 Comments

image: Gene Editing Treats Blood Disease

Gene Editing Treats Blood Disease

By Annie Gottlieb | June 27, 2011

Revising a dysfunctional gene in vivo for the first time, researchers successfully restore blood clotting in hemophiliac mice.

0 Comments

Popular Now

  1. Salk Institute Suspends Cancer Scientist Inder Verma
  2. Long-Term Study Reveals Flip in Plant Responses to Carbon Dioxide
  3. Jim Bridenstine Confirmed to Lead NASA
  4. RNA Injection Restores Hearing in Guinea Pigs